#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia refractory Burkitt's lymphoma Niemann-Pick disease Acute myeloid leukaemia Encephalopathy neonatal Focal segmental glomerulosclerosis Endometrial cancer recurrent Epidermolysis bullosa Netherton's syndrome Renal cancer metastatic Loeys-Dietz syndrome Ventricular tachycardia Basal cell naevus syndrome Haemophilia A with anti factor VIII Arterial disorder More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Diagnostics Encephalitis autoimmune – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Lysosomal storage disorder – Treatment Osteosarcoma recurrent – Trials in Disease Metachromatic leukodystrophy – Trials in Disease Glomerulonephritis membranoproliferative – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Fragile X syndrome – Basic Information Mast cell activation syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meglumine Gadoterate Cagrilintide Perflutren Pirfenidone Afamelanotide Heterodimeric Interleukin-15 Motixafortide Mavorixafor Bleomycin Sulfate Petrelintide GVV858 Simvastatin Acp-204 Tartrate Acasunlimab Gsk4004280 Etifoxine Hydrochloride Ag-946 Giroctocogene Fitelparvovec Lactic Acid Cusatuzumab More therapies…

    Learn about Your Condition

    Exposure via breast milk Perineal injury Post-traumatic stress disorder Pituitary tumour benign Respiratory failure Factor IX deficiency Epicondylitis Oesophagogastroscopy Deafness traumatic Ocular melanoma Metastatic neoplasm Macular telangiectasia Facial paresis Paresis Hypotonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Temozolomide
    Austria Denmark Norway Sweden

  • Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Sabestomig
    • Volrustomig
    • Azd0901
    Spain

  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Aldesleukin
    • Glucose
    Germany

  • Study of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    • Axial spondyloarthritis
    Investigated Drugs:
    • Ixekizumab
    Denmark

  • Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Olaptesed Pegol
    • Bevacizumab
    • Pembrolizumab
    Germany

  • Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia Denmark France Germany +3
Previous Page
1 … 461 462 463 464 465 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!